Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 30, 2019

SELL
$219.29 - $241.72 $2.95 Million - $3.25 Million
-13,431 Closed
0 $0
Q1 2019

Apr 12, 2019

BUY
$216.71 - $338.96 $1.19 Million - $1.86 Million
5,496 Added 69.26%
13,431 $3.18 Million
Q4 2018

Jan 30, 2019

BUY
$278.5 - $352.75 $2.03 Million - $2.58 Million
7,305 Added 1159.52%
7,935 $2.39 Million
Q3 2018

Oct 25, 2018

SELL
$293.51 - $383.83 $187,552 - $245,267
-639 Reduced 50.35%
630 $223,000
Q2 2018

Aug 03, 2018

BUY
$257.52 - $306.91 $94,509 - $112,635
367 Added 40.69%
1,269 $368,000
Q1 2018

May 03, 2018

SELL
$260.13 - $367.91 $1.24 Million - $1.75 Million
-4,761 Reduced 84.07%
902 $247,000
Q4 2017

Feb 08, 2018

BUY
$307.64 - $344.58 $119,364 - $133,697
388 Added 7.36%
5,663 $1.8 Million
Q3 2017

Oct 19, 2017

BUY
$281.15 - $329.69 $1.48 Million - $1.74 Million
5,275
5,275 $1.65 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $26.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Transform Wealth, LLC Portfolio

Follow Transform Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Transform Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transform Wealth, LLC with notifications on news.